Whole Blood 5-Hydroxytryptamine during Treatment of Endogenous Depressive Illness
- 1 May 1973
- journal article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 122 (570) , 597-598
- https://doi.org/10.1192/bjp.122.5.597
Abstract
In the course of a study on endogenous depressive illness, whole blood 5-hydroxytryptamine (5HT) has been recorded in sixteen in-patients at Roffey Park Hospital. Thirteen patients received L-tryptophan 1 G t.d.s. and 3 G nocte, of whom two received in addition phenelzine 15 mg. b.d. for 48 hours followed by 30 mg. b.d. thereafter. Three patients received amitriptyline 25 mg. b.d. and 50 mg. nocte for 48 hours followed by 50 mg. b.d. and 75 mg. nocte thereafter. One patient receiving Ltryptophan had essential hypertension and received α-methylDOPA throughout. Observation continued for six weeks.Keywords
This publication has 2 references indexed in Scilit:
- Estimation of 5-hydroxytryptamine in human bloodClinica Chimica Acta; International Journal of Clinical Chemistry, 1964
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960